Stockholm3 Advanced Prostate Blood Test
Book the Stockholm3 Blood Test in the UK with Vitalync Diagnosis. Advanced prostate cancer risk assessment combining PSA, biomarkers, genetics and clinical data for more accurate screening.
What's included in this profile
About this profile
The Stockholm3 Blood Test is an advanced prostate cancer risk assessment blood test designed to provide a more accurate evaluation than a standard PSA test alone. It combines protein biomarkers, genetic markers and clinical information using an advanced algorithm to assess the risk of clinically significant prostate cancer.
Why Choose Stockholm3 Instead of PSA Alone?
Traditional PSA testing can sometimes:
- Miss aggressive prostate cancers
- Detect non-aggressive cancers unnecessarily
- Lead to unnecessary MRI scans or biopsies
Stockholm3 improves risk assessment by combining multiple data points rather than relying on PSA alone. Clinical studies have shown that Stockholm3 may help reduce unnecessary biopsies and improve detection of clinically significant prostate cancer.
Key Benefits
- More advanced than PSA testing alone
- Improved assessment of aggressive prostate cancer risk
- Helps support MRI and biopsy decisions
- May reduce unnecessary investigations
- Simple blood sample collection
- Suitable for proactive men’s health screening
Who Is This Test For?
The Stockholm3 Blood Test may be suitable for:
- Men aged 45–74
- Men with elevated or borderline PSA results
- Individuals with a family history of prostate cancer
- Men seeking a more detailed prostate cancer risk assessment
What Happens After the Test?
Your results provide a personalised prostate cancer risk score. Depending on the outcome, further clinical review, MRI imaging or specialist urology referral may be recommended.
This test does not diagnose prostate cancer on its own. Further investigations may still be required where clinically appropriate.
